Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brenda Huppke

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Neuropediatrics|December 5, 2024
Severe Disease Activation after Fingolimod Discontinuation in a Pediatric Multiple Sclerosis Patient: A Case Report and Literature ReviewBrenda Huppke, Heike de Vries, Astrid Blaschek, et al.
Pediatric Neurology|August 12, 2009
Immunoglobulin therapy in idiopathic hypothalamic dysfunctionPeter Huppke, Alexander Heise, Kevin Rostasy, et al.
Pediatric Neurology|August 22, 2025
Rett Syndrome: Specific MECP2 Variants are Associated With Elevated Serum Neurofilament Light ChainEmma Hirn, Brenda Huppke, Bernd Wilken, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2026
Serum neurofilament light chain in paediatric patients treated with natalizumab for highly active multiple sclerosisBrenda Huppke, Marie-Christine Reinert, Wiebke Stark, et al.
Archives of Neurology|December 10, 2008
Natalizumab use in pediatric multiple sclerosisPeter Huppke, Wiebke Stark, Claudia Zürcher, et al.
International Journal of Molecular Sciences|July 29, 2023
Evaluation of Novel Enhancer Compounds in Gentamicin-Mediated Readthrough of Nonsense Mutations in Rett SyndromeKeit Men Wong, Eike Wegener, Alireza Baradaran-Heravi, et al.
JAMA Neurology|July 16, 2019
Association of Obesity With Multiple Sclerosis Risk and Response to First-line Disease Modifying Drugs in ChildrenBrenda Huppke, David Ellenberger, Hannah Hummel, et al.
Neurology|September 25, 2023
Pretreatment Neurofilament Light Chain Serum Levels, Early Disease Severity, and Treatment Response in Pediatric Multiple SclerosisBrenda Huppke, Marie-Christine Reinert, Hannah Hummel-Abmeier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2017
Therapy of highly active pediatric multiple sclerosisPeter Huppke, Brenda Huppke, David Ellenberger, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2012
Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patientsPeter Huppke, Kevin Rostasy, Michael Karenfort, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Neuropediatrics|December 5, 2024
Severe Disease Activation after Fingolimod Discontinuation in a Pediatric Multiple Sclerosis Patient: A Case Report and Literature ReviewBrenda Huppke, Heike de Vries, Astrid Blaschek, et al.
Pediatric Neurology|August 12, 2009
Immunoglobulin therapy in idiopathic hypothalamic dysfunctionPeter Huppke, Alexander Heise, Kevin Rostasy, et al.
Pediatric Neurology|August 22, 2025
Rett Syndrome: Specific MECP2 Variants are Associated With Elevated Serum Neurofilament Light ChainEmma Hirn, Brenda Huppke, Bernd Wilken, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2026
Serum neurofilament light chain in paediatric patients treated with natalizumab for highly active multiple sclerosisBrenda Huppke, Marie-Christine Reinert, Wiebke Stark, et al.
Archives of Neurology|December 10, 2008
Natalizumab use in pediatric multiple sclerosisPeter Huppke, Wiebke Stark, Claudia Zürcher, et al.
International Journal of Molecular Sciences|July 29, 2023
Evaluation of Novel Enhancer Compounds in Gentamicin-Mediated Readthrough of Nonsense Mutations in Rett SyndromeKeit Men Wong, Eike Wegener, Alireza Baradaran-Heravi, et al.
JAMA Neurology|July 16, 2019
Association of Obesity With Multiple Sclerosis Risk and Response to First-line Disease Modifying Drugs in ChildrenBrenda Huppke, David Ellenberger, Hannah Hummel, et al.
Neurology|September 25, 2023
Pretreatment Neurofilament Light Chain Serum Levels, Early Disease Severity, and Treatment Response in Pediatric Multiple SclerosisBrenda Huppke, Marie-Christine Reinert, Hannah Hummel-Abmeier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2017
Therapy of highly active pediatric multiple sclerosisPeter Huppke, Brenda Huppke, David Ellenberger, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2012
Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patientsPeter Huppke, Kevin Rostasy, Michael Karenfort, et al.
Pageof 2